Kura Oncology: Wedbush lowers PT to $36 from $38, maintains Outperform rating.

viernes, 6 de marzo de 2026, 9:04 am ET1 min de lectura
KURA--

Kura Oncology: Wedbush lowers PT to $36 from $38, maintains Outperform rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios